SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-19-205660
Filing Date
2019-07-29
Accepted
2019-07-29 17:27:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D d768139dsc13d.htm SC 13D 33697
  Complete submission text file 0001193125-19-205660.txt   35065
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Subject) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88731 | Film No.: 19982520
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2450 HOLCOME BLVD. SUITE J-608 HOUSTON TX 77021
Business Address
Northrup Jonathan P (Filed by) CIK: 0001770559 (see all company filings)

Type: SC 13D